Clinical Trial

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

Study acronym: VASCinFABRY
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to gain a deeper understanding of endothelial dysfunction in patients with Fabry disease through a prospective study of the retinal microvasculature and to identify an objective, non-invasive marker to assess disease severity and cardiovascular risk in patients. The main questions addressed are: Do dynamic and static retinal vessel analysis parameters differ from those in healthy individuals? Can these parameters predict cardiovascular and/or Fabry-related events during follow-up? Do these parameters change during follow-up in patients with a non-stable disease?
Trial Details
NCT Number NCT06758648
Lead Sponsor Technical University of Munich
Collaborators: Takeda
Conditions Fabry Disease, Endothelial Dysfunction, Microvasculature
Enrollment 63 participants
Start Date 2020-06-25
Primary Completion 2021-09-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-06